author-photo

Dzhariyat Shikhbabaeva

23

Papers

21

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Development and Validation Results of the Russian MPN10 Form for Symptom Assessment in Patients with Myeloproliferative Neoplasms in Compliance with International Recommendations

2020 Clinical oncohematology
Show All
- Source
- Cite
- Save
Citations (0)
THE POTENTIAL IMPACT OF SWITCH TO SECOND GENERATION TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE WHO HAD NO OPTIMAL RESPONSE TO 3 MONTHS OF INITIAL IMATINIB THERAPY: PS1183

2019
Show All
- Source
- Cite
- Save
Citations (0)
A RETROSPECTIVE ANALYSIS OF IMMUNE THROMBOCYTOPENIA PATIENTS TREATMENT RESULTS AFTER SEQUENTIAL SWITCHING OF THROMBOPOIETIC RECEPTOR-AGONISTS: PS1106

2019
Show All
- Source
- Cite
- Save
Citations (0)
EVALUATION OF THROMBOPOIETIN-RECEPTOR AGONISTS (TPO-RAS) «STOP-THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): PF336

2019
Show All
- Source
- Cite
- Save
Citations (0)
PF-114: A 4th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1T315I

2019 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

2017 Clinical oncohematology
Show All
- Source
- Cite
- Save
Citations (0)
Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera

2017 Clinical oncohematology
Show All
- Source
- Cite
- Save
Citations (1)
It Is Safe to Change Horses in the Midstream - 3-Year Experience of Treating CML Patients with Imatinib Generics

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Devil Is Not As Black As He Is Painted - 3-Year Experience of Treating Newly Diagnosed CML Patients with Imatinib Generics

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Targeted therapy of polycytemia vera patients.

2016 Voprosy onkologii
Show All
- Source
- Cite
- Save
Citations (0)